
NeuroPace Investor Relations Material
Latest events

Q4 2024
NeuroPace
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from NeuroPace Inc
Access all reports
NeuroPace, Inc. designs and develops devices to treat patients with refractory epilepsy. The company offers RNS System, a responsive neurostimulator device that is attached to the patient's skull, like a halo, and stimulated their brain with tiny electrical pulses. In addition, its product pipeline comprises RNS Stimulator to replace the traditional battery-powered pacemaker described above with a wireless charger; and rechargeable battery; wireless charger that eliminates the need to physically remove the device from the patient’s head in order to power up the battery; RNS Remote Monitor that enables patients to use an iPad application to indicate when they are having seizures or any other relevant symptoms; and RNS Access Manager that serves as an ingenious monitor for physicians and nurses treating patients. NeuroPace, Inc. was founded in 1997 and is headquartered in Mountain View, California.
Key slides for NeuroPace Inc


Q4 2024
NeuroPace Inc


43rd Annual J.P. Morgan Healthcare Conference 2025
NeuroPace Inc
Latest articles
)
James Quincey: Coca-Cola Chairman and CEO
James Quincey has dedicated nearly three decades to The Coca-Cola Company, rising through the ranks to become CEO and Chairman of the company.
11 Mar 2025
)
PepsiCo: From Pepsi and Gatorade to Doritos and Lay's
PepsiCo has grown from a soda company into a global leader in food and beverages, with a portfolio of over 200 brands, including Pepsi, Lay's, and Gatorade.
11 Mar 2025
)
Bob Iger: Disney's Visionary CEO
Bob Iger is a legend in the entertainment industry, known for his visionary leadership and as one of the most influential CEOs in Disney's history.
10 Mar 2025
Ticker symbol
NPCE
Country
🇺🇸 United States